ICG's FRE Guidance Shift and Zero-Debt Path Mark a Strategic Inflection

ICG delivered a full-year 2026 that was as much about repositioning as about numbers. The firm reported FRE of GBP 350 million, up 23%, with operating cash flow of GBP 861 million and fee-earning AUM up 11% to $87 billion. But the more consequential development was a deliberate shift in how the company frames its growth: new guidance centered on FRE margin expansion, a move that aligns ICG with the global alternative-asset peer set and signals confidence in operating leverage.

A New Financial Frame: FRE Takes Center Stage

David Bicarregui, CFO, opened the financial review by reinforcing the link between strategy and the evolved presentation: “We are reporting FRE of GBP 350 million, up 23% year-on-year.” — David Christopher Bicarregui, Chief Financial Officer · 2026-05-21 More importantly, the company replaced its medium-term guidance on FMC margin with a commitment to expand FRE margin over time. This is a clear attempt to make ICG comparable to global peers and to highlight the compounding effect of fee earning AUM growth and cost control. The FRE margin, ex catch-up fees, has already risen from 33% to 47% over five years, and management now expects continued accretion. The shift is not cosmetic; it changes how investors will judge the company’s trajectory.

We are going to accrete FRE margin over time. It will be lumpy in a given year because of the fundraising cycle and the way that management fees are recorded. But fundamentally and structurally, we can accrete FRE margin from here.

Fundraising Momentum and the Amundi Opportunity

Fundraising surprised to the upside, with $17 billion raised versus expectations, and 34% of capital from North America. Europe IX has crossed EUR 10 billion, making it ICG’s first commingled fund above that threshold. The scaling strategies in real assets—Infrastructure II and Metro I—closed their second vintages, a milestone Benoit Durteste called “a critical milestone” for cementing reputation. These successes support the thesis that ICG is gaining market share in a consolidating industry.

The Amundi partnership, announced in November, is moving from paper to product. Durteste noted: “We reinforced our scaled competitive position, beat by some margin, our fundraising targets, established a strategic relationship with Amundi...” — Benoît Durteste, Chief Executive Officer · 2026-05-21 He also revealed that a SICAV filing was made with the CSSF in Luxembourg just days before the call, a concrete step toward the wealth channel. This is a theme that recurred in the prior call, where Durteste said of the private-wealth potential: “The potential there is undeniably very significant.” — Benoît Durteste, CEO · 2025-11-18 The difference now is execution and a clear timeline.

Selective Deployment, Strong Balance Sheet

Deployment remains disciplined, with $14 billion invested and $7 billion realized. Durteste emphasized caution, especially in direct lending and secondaries, despite substantial dry powder of $36 billion. He said: “you also need to be conscious of the risk out there and remain quite selective and cautious, which has always been--that's what we're known for.” — Benoît Durteste, Chief Executive Officer · 2026-05-21 The balance sheet returned 5% for the year, below the long-term double-digit target, but the co-investment portfolio generated nearly GBP 500 million in net cash flow. The structural trend toward lower commitments in successive vintages is making the balance sheet increasingly cash-generative.

This cash generation is the foundation of a new capital allocation debate. The company is close to hitting zero net debt (currently GBP 113 million, down from GBP 629 million). Once there, all options are on the table, as David Bicarregui laid out in the Q&A:

Once we reach a position of zero net debt, we will continue to allocate thoughtfully. In this regard, all options are on the table, optimizing co-investments alongside our existing products and strategies, seeding new products and strategies, making strategic investments, whether in M&A or partnerships more broadly and of course, returning capital to shareholders through dividends or buybacks.

This is a meaningful shift from the past, where the discount to peers made buybacks less attractive. Durteste acknowledged that the pain in the broader alternative asset management industry could create opportunities for ICG to accelerate growth, possibly through acquisitions.

ICG is not alone in emphasizing these metrics. StepStone (STEP), another private-markets firm reporting this week, also highlighted Fee earning AUM growth and performance fees, underscoring that the industry is converging on FRE as the standard measure of value creation. For ICG, the combination of a strategic partnership in wealth, a strong fundraising cycle, and the impending inflection to a net cash position makes this an unusually active moment.

What changed? The company did not just beat expectations—it repositioned its financial narrative to embrace a more comparable, growth-oriented framework. The zero-debt milestone is now visible on the horizon, and management is openly discussing buybacks and M&A as credible tools. The next few quarters will test whether the FRE margin expansion holds and whether the Amundi partnership delivers the promised flow. For now, ICG has made a compelling case that its focus on Performance fee generation and cost discipline is starting to pay off in ways that shareholders can measure.